Variant report

Variant	rs11794425
Chromosome Location	chr9:95820023-95820024
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ZEB1	chr9:95819798-95820072	GM12878	blood:	n/a	n/a

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:95819533..95824260-chr9:95855982..95859349,6	K562	blood:
2	chr9:95818120..95822805-chr9:95894646..95898384,4	K562	blood:
3	chr9:95795131..95797013-chr9:95818973..95820858,2	K562	blood:
4	chr9:95818455..95825266-chr9:95831322..95836031,9	K562	blood:
5	chr9:95816364..95826268-chr9:95852309..95863275,20	MCF-7	breast:
6	chr9:95818697..95822651-chr9:95855885..95860349,6	MCF-7	breast:
7	chr9:95819594..95823966-chr9:95894549..95897415,5	MCF-7	breast:
8	chr9:95819521..95827100-chr9:95855273..95859349,14	K562	blood:
9	chr9:95818234..95820974-chr9:96339140..96341685,2	MCF-7	breast:

No data

Variant related genes	Relation type
SUSD3	TF binding region
ENSG00000223446	Chromatin interaction
ENSG00000131669	Chromatin interaction
ENSG00000165233	Chromatin interaction
ENSG00000157303	Chromatin interaction

Extended variants
information (count: 15 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:7)

rs_ID	r²[population]
rs11790147	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs11790662	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs56988496	1.00[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs59221745	0.82[AFR][1000 genomes]
rs60481048	0.97[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs62573565	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs7859904	0.91[AFR][1000 genomes];0.94[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv526296	chr9:95708192-96030392	Enhancers Bivalent/Poised TSS Weak transcription Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	30 gene(s)	inside rSNPs	diseases
2	nsv1054767	chr9:95738134-95875977	Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Enhancers Genic enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
3	nsv1035230	chr9:95770249-95934982	Weak transcription Active TSS Flanking Active TSS Enhancers Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
4	nsv893575	chr9:95781040-95854013	Strong transcription Flanking Active TSS Weak transcription Active TSS Enhancers ZNF genes & repeats Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
5	nsv893576	chr9:95789960-96158277	Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
6	esv1824329	chr9:95811604-95921347	Strong transcription Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
7	nsv893577	chr9:95812707-95872216	Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
8	nsv893578	chr9:95818641-95887320	Weak transcription Enhancers Strong transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:60 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:95812000-95821000	Weak transcription	Gastric	stomach
2	chr9:95812800-95820400	Weak transcription	Placenta	Placenta
3	chr9:95814400-95821000	Weak transcription	Pancreas	Pancrea
4	chr9:95814600-95820400	Weak transcription	Right Ventricle	heart
5	chr9:95814600-95820800	Enhancers	Primary T helper cells fromperipheralblood	blood
6	chr9:95814800-95820400	Weak transcription	Liver	Liver
7	chr9:95814800-95820600	Weak transcription	Colon Smooth Muscle	Colon
8	chr9:95814800-95820600	Weak transcription	Skeletal Muscle Male	skeletal muscle
9	chr9:95815000-95821000	Weak transcription	Aorta	Aorta
10	chr9:95815600-95820600	Weak transcription	Stomach Smooth Muscle	stomach
11	chr9:95816400-95820200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr9:95816400-95820600	Weak transcription	Lung	lung
13	chr9:95816400-95820800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr9:95817400-95820200	Enhancers	Primary neutrophils fromperipheralblood	blood
15	chr9:95817400-95820200	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
16	chr9:95817400-95820200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
17	chr9:95817400-95820600	Weak transcription	Fetal Lung	lung
18	chr9:95817400-95821000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr9:95817600-95820200	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
20	chr9:95818000-95820600	Weak transcription	Adipose Nuclei	Adipose
21	chr9:95818000-95820600	Weak transcription	Duodenum Mucosa	Duodenum
22	chr9:95818400-95820600	Weak transcription	Monocytes-CD14+_RO01746	blood
23	chr9:95818400-95821000	Weak transcription	Primary monocytes fromperipheralblood	blood
24	chr9:95819000-95821000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
25	chr9:95819000-95821000	Enhancers	Primary hematopoietic stem cells short term culture	blood
26	chr9:95819200-95820400	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr9:95819200-95820600	Enhancers	HUES6 Cell Line	embryonic stem cell
28	chr9:95819200-95820600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr9:95819200-95820600	Enhancers	Primary T cells fromperipheralblood	blood
30	chr9:95819200-95820800	Enhancers	Thymus	Thymus
31	chr9:95819200-95821000	Enhancers	Fetal Thymus	thymus
32	chr9:95819400-95820200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr9:95819400-95820400	Enhancers	Ovary	ovary
34	chr9:95819400-95820600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
35	chr9:95819400-95820600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr9:95819400-95820600	Enhancers	Fetal Stomach	stomach
37	chr9:95819400-95820600	Weak transcription	Left Ventricle	heart
38	chr9:95819400-95820800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
39	chr9:95819400-95821000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr9:95819600-95820200	Strong transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr9:95819600-95820400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
42	chr9:95819600-95820400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
43	chr9:95819600-95820600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
44	chr9:95819600-95820800	Enhancers	Primary T helper naive cells from peripheral blood	blood
45	chr9:95819600-95821000	Enhancers	Primary B cells from peripheral blood	blood
46	chr9:95819600-95821200	Enhancers	Primary hematopoietic stem cells	blood
47	chr9:95819800-95820200	Weak transcription	Fetal Intestine Small	intestine
48	chr9:95819800-95820400	Enhancers	Spleen	Spleen
49	chr9:95819800-95820600	Weak transcription	Duodenum Smooth Muscle	Duodenum
50	chr9:95819800-95820600	Flanking Active TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links